Graft-versus-host disease following interleukin-2/lymphokine-activated killer (LAK) cell immunotherapy in a patient with acute myelogenous leukaemia in second complete remission: autologous LAK cells following allogeneic bone marrow transplantation are donor-derived
Brian J. Boughton, Andrew W. Simpson, Trevor A. J. Phaure, Cynthia BeattyVolume:
41
Year:
1995
Language:
english
Pages:
3
DOI:
10.1007/bf01788962
File:
PDF, 638 KB
english, 1995